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Abstract Elucidating the temporal natural history of
Hepatitis B virus (HBV) infection provides not only useful
information for assessing the spread of HBV infection but
also a bedrock for economic appraisal of population-based
preventive strategies (such as universal vaccination). HBV
transmissions are transmitted through the maternal (verti-
cal) route and environmental (horizontal) route. As the
infection process from susceptible to active virus replica-
tion and finally to recovery state or to carrier state through
both routes is not directly observable, mathematical models
were therefore proposed to quantitatively elucidate the
dynamic process of HBV infection with time. We began
with a simple two-state model (from susceptible to infec-
tion) and further developed a five-state (including suscep-
tible, latent phase, active viral replication, carrier, and
recovery states) stochastic process to quantify the dynam-
ics of HBV infection, making allowances for a mixed
proportion of vertical and horizontal transmissions. The
data used in the estimation, which were collected before
implementation of a policy for universal HBV vaccination,
were derived from several previous serum prevalence
studies, including both low (northern) and high (southern)
HBV prevalence areas, in Taiwan. The parameters
obtained from stochastic models were converted to com-
pute the basic reproductive number (R0) in each study to
indicate the extent of the spread of HBV infection. By
linking the temporal natural history of HBV infection with
the previously established Markov process for the sequelae
of HBV infection (chronic hepatitis infection, liver cir-
rhosis, and hepatocelluar carcinoma), we developed a
Markov cycle decision tree to evaluate the two population-
based preventive strategies related to vaccination and
maternal lamivudine use with a cost-effectiveness analysis.
In the five-state model, horizontal transmission was found
to contribute more to HBV infection than vertical trans-
mission in the northern area (59 vs. 41 %), whereas vertical
transmission was more likely than horizontal transmission
in the southern area (80 vs. 20 %). After considering the
parameters of the two transmission routes, annual infection
rate (person-years) for susceptible subjects was higher in
the northern area (0.35) than the southern area (0.011). A
similar finding was noted for annual rate of the transition
from the latent period to active viral replications (1.12 in
the northern area and 0.072 in the southern area). Annual
rate of the conversion from active viral replication to the
carrier state was higher in the southern area (0.184) than
the northern area (0.119). Annual recovery rates were
0.014 in the northern area and 0.024 in the southern area
for the carrier and 0.048 and 0.088 for transient viremia.
The R0 at age 30 using the parameters obtained from the
five-state stochastic model was estimated as 4.88 in the
northern and 7.03 in the southern area. Regarding the
findings of economic appraisal, both preventive strategies
were cost-saving, yielding the negative value of
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incremental cost-effectiveness ratio, compared with the
baseline group (no intervention), regardless of areas. The
preventive strategies in the southern area were more cost-
saving than those in the northern area. The consolidation of
elucidating the temporal natural history of HBV infection,
estimating basic reproductive number, and conducting an
economic appraisal of population-based preventive strategy
can aid health policy-makers in designing effective pre-
ventive strategies in other countries worldwide where HBV
is still prevalent. However, the empirical findings on
transmission routes and the temporal evolution of HBV
infection varying with areas should be considered with
great caution as only two studies were modeled.
Keywords Hepatitis B  Infection  Reproductive
number  Stochastic model
1 Introduction
The temporal natural history of hepatitis B virus (HBV)
infection and its sequale (such as chronic hepatitis, liver
cirrhosis, and hepatocellular carcinoma) are long and het-
erogeneous (Chu 2000; Liaw and Chu 2009). The pano-
rama of the evolutionary process is often defined as a kind
of chronic infectious disease. To assess the spread of HBV
infection and to conduct an economic appraisal of popu-
lation-based preventive strategies of reducing its sequale, it
is indispensable to understand the temporal natural history
of HBV infection and the subsequent progressions to var-
ious chronic liver diseases and even death from HCC.
Regarding the dynamic HBV infection process, it is well
documented that hepatitis B virus infection is contracted by
either vertical transmission through maternal route or hori-
zontal transmission through environmental routes (includ-
ing the sharing of personal hygiene facilities, occupational
exposure during medical procedures, the sharing of syrin-
ges, the process of getting tattoos, and sexual intercourse)
(Kao and Chen 2002). After entering into the susceptible
host, the virus starts to propagate. The time interval required
for the propagation is defined as latent period after exposure
to HBV. As acute infection may occur due to active virus
replication, the infected subject becomes highly contagious
(an infective case). In the wake of acute infection, one can
either recover or become a chronic carrier detected by the
presence of HBsAg (the surface antigen of HBV) for more
than 6 months. This dynamic process of HBV infection for
an individual from being susceptible until recovery or
becoming a carrier is diagrammed in the upper panel of
Fig. 1. Elucidating the natural history of HBV infection
provides insight into the design and planning of preventive
strategies of HBV infection by considering both mother-
acquired and environment-driven transmissions. In addition
to the individual temporal natural history of HBV infection,
the dynamic process of such HBV infection can also be
characterized from the population viewpoint by contact rate,
transmission probability, and recovery rate, which are three
measures that give the estimated basic reproductive number
(R0), an indicator of the number of secondary cases pro-
duced by a primary case in traditional infectious disease
models, including the widely used susceptible-infectious-
recovered (SIR) model (Anderson et al. 1992). Numerous
studies have been devoted to estimating this indicator for
various infectious diseases (Pybus et al. 2001; Yang et al.
2009). Two studies have already focused on modeling the
effect of vaccination or antivirus treatment on the trans-
mission, the prevalence, and the incidence of HBV infection
(O’Leary et al. 2010; Pang et al. 2010). The effect of unsafe
injection on HBV infection and also HIV cross-infection has
been also elucidated with a mathematical model (Aylward
et al. 1995). However, the application of the SIR or related
models to a chronic infectious disease such as hepatitis B
virus (HBV) infection and HCC and its related diseases is
often subject to whether the temporal natural history of the
infection process is well understood and whether the data are
directly observed during the infectious process.
There are several obstacles to applying conventional
infectious disease models to the temporal natural history of
HBV infection in order to estimate R0. It is not possible to
distinguish between vertical and horizontal transmission for
HBV on the basis of serological surveys of antibodies to the
HBV core protein (anti-HBc), which are indicative of past
infections only (Stevens et al. 1975, 1985; Ni et al. 2007;
Tseng et al. 2011). This complicates the understanding of
the HBV transmission process through environmental and
maternal routes. The risk of chronic infection is highest
among those who acquired infection early in life (Stevens
et al. 1975, 1985; Ni et al. 2007; Tseng et al. 2011). In
addition to vertical transmission, viral latency before pro-
gressing to active viremia cannot be distinguished from
recovery after resolution. More importantly, it is often dif-
ficult to know the exact time of intermediate states when a
specific state is observed using survey results. For example,
a carrier identified by the presence of both HBV surface and
internal antigens (HBsAg and HBeAg, respectively) at time
t had entered the latent state at time s and evolved into active
viremia at time u, where s \ u \ t. To tackle the mixture of
both the transmission and censored problems relating to
time to different disease states as shown in Fig. 1, a five-
state stochastic process was therefore proposed to estimate
the parameters based on the empirical data prior to the
introduction of HBV vaccine and to translate these param-
eters into the estimated R0.
More importantly, as HBV infection is a chronic
infection disease, it may progress throughout the carrier’s
lifetime to severe liver-related diseases, including chronic
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acute hepatitis, compensated and decompensated liver
cirrhosis, HCC, and death, as shown in the bottom panel of
Fig. 1. The process of its sequale has been previously
modeled by another Markov model (Crowley et al. 2000).
However, the link between the dynamic HBV infectious
process with emphases on both horizontal and vertical
transmissions and the Markov model for sequale has been
barely addressed. To relate the estimated parameters gov-
erning the natural history of HBV infection to its sequale,
particularly the destination of death from HCC, is a sine
qua non for a cost-effectiveness analysis of various popu-
lation-based preventive strategies of reducing long-term
outcomes such as HCC and death.
The aims of this study were therefore several-fold and
achieved with a step-by-step procedure. These included the
application of a simple two-state model (susceptible and
infection) and the development of a five-state stochastic
process for modeling the temporal natural history of HBV
infection from susceptible state to carrier or recovery state
by considering a mixture of both vertical and environ-
mental transmissions. We then applied this process model
to two empirical Taiwanese datasets, one for southern and
one for northern areas, that contained sufficient information
to define different states of the temporal natural history of
HBV infection so as to estimate the parameters. The R0
was therefore computed by simulating the proportion of
susceptible population based on the estimated parameters.
The corresponding basic reproductive numbers were also
computed on the basis of a simple two-state model (only
considering the transition process between susceptible and
infection) based on the seven empirical datasets (five
empirical datasets together with the two Taiwanese data-
sets used in the five-state stochastic model). The compar-
isons of R0 were then made between the five-state
stochastic model and the two-state model. Finally, by
linking the temporal natural history of HBV infection
underpinning the five-state stochastic model with the se-
quale of HBV infection captured by the previously devel-
oped Markov model, a cost-effectiveness analysis was
conducted to evaluate the two population-based preventive
strategies (universal vaccination plus and hepatitis B
immunoglobulin (HBIG) injection (strategy 1) and the
lamivudine-treated group with routine vaccination (strat-
egy 2)) compared with the baseline group (no intervention).
2 Materials and method
2.1 Data
To model the natural transmission dynamics of HBV
illustrated in the upper panel of Fig. 1, empirical data were
needed before any population-based preventive strategy
(such as universal vaccination plus and hepatitis B immu-
noglobulin (HBIG) injection and the lamivudine-treated







Fig. 1 Temporal natural history model for hepatitis B virus infection
and the Markov process of its sequelae. f Fraction of vertical
transmission, k infection rate after birth, a rate of transition to active
viral replication, m recovery rate for carrier, x recovery rate for active
viral replication, e carrier rate. The upper panel is to delineate the
states in hollow circles representing the temporal natural history for
hepatitis B virus infection in which the relevant parameters were
estimated in different studies listed in Table 1. The lower panel is to
delineate the states in shadowed circles representing for the sequales
following asymptomatic carrier. The two processes were articulated
as a unified Markov process model for the cost-effectiveness analysis
of the two preventive strategies for hepatitis B virus infection
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best of our knowledge, few empirical studies that were
conducted before universal vaccination could be used to
estimate the dynamic process of HBV infection. We sear-
ched relevant articles through the computerized databases
Medline, and the Cochrane electronic library by combining
several keywords ‘‘Hepatitis B’’ with the either of other
three words ‘‘serology’’, ‘‘prevalence’’, and ‘‘epidemiol-
ogy’’. Furthermore, the reference lists of published articles
were also used to search for other relevant studies.
The inclusion criteria for selecting studies consisted of the
following: (1) the studies conducted between 1902 and 1990
(the time near the implementation of universal HBV vacci-
nation); (2) the studies published in an English-language
peer-reviewed journal; (3) the studies having available data
on serological markers for the two-state model and the five-
state model. The details of the respective study designs have
been described in full elsewhere and are summarized in
Table 1 (Sung et al. 1984; Hsu et al. 1986; Chung et al. 1988;
Wu et al. 1980; Yodfat et al. 1982; Kashiwagi et al. 1983;
Chen et al. 1987). All seven studies included the measure-
ment of anti-HBc, which was necessary for the two-state
model (susceptible versus infection). For the five-state
model (see below), given that the measurements of HBsAg,
anti-HBc, and HBeAg were necessary, data from only two
studies in northern (Study 1) and southern (Study 2) areas of
Taiwan were retrieved. One study in the capital of Taiwan
(Study 3) also contained this information, but since it only
followed individuals up to 15 years of age, this dataset could
not be used for the five-state model.
With the available seroprevalence data, states were
defined as follows. The latent and recovery states were
defined by the presence of anti-HBc, whereas the suscep-
tible state was denoted by a negative result. The presence
of HBeAg and HBsAg represented active viral replication
and carrier, respectively. The rest of this section is orga-
nized into three parts. Section 2.2 specifies how we
constructed the two-state and five-state models of the
temporal natural history of HBV infection. Section 2.3
delineates how we estimated R0 by the application of those
transmission parameters. Section 2.4 demonstrates how we
evaluated the efficacy of various population-based pre-
ventive strategies (universal vaccination plus and hepatitis
B immunoglobulin (HBIG) injection and the lamivudine-
treated group with routine vaccination) based on the results
of the other two sections.
2.2 Model specification for temporal natural history
of HBV infection
Following Anderson et al. (1992), the temporal natural
history model of infectious disease was proposed by
including susceptible, infective, and immune or recovery
states. To develop a model with a step-by-step procedure,
we began with a two-state model delineating the simplest
form of HBV infection, from susceptible to infection,
according to the presence of anti-HBc (Table 1). This two-
state model was essentially the accelerated failure time
model used for the parametric survival analysis (Collett
2003). In this parametric analysis, we applied three dif-
ferent distributions for time of transition from susceptible
to infection, including the exponential, Weibull, and log-
logistic functions, to test the assumption whether the
transition hazard rate was constant over time (with expo-
nential distribution) or varied with time (with Weibull and
log-logistic distribution).
As a subject with HBV infection may be still an infec-
tious carrier even after the relief of symptoms in the case,
the basic two-step model was extended to a five-state
model that is composed of susceptible, latent period, active
viral replication, carrier, and immune status. Transmission
modes, including vertical and horizontal transmissions,
were also quantified (Fig. 1).
Table 1 Brief summary of previous studies






Used both in the two- and five-state models
1 (Taipei, Taiwan)* 1,354 1984 0–70 Yes Yes Yes Yes Sung et al. (1984)
2 (Pingtung, Taiwan)* 1,200 1988 5–69 Yes Yes Yes Yes Chung et al. (1988)
Used only in the two-state model
3 (Taipei, Taiwan) 1,200 1986 0–15 Yes Yes Yes Yes Hsu et al. (1986)
4 (Taipei, Taiwan) 503 1980 0–70 Yes Yes Yes No Wu et al. (1980)
5 (Kaohsiung, Taiwan) 4,081 1987 1–86 Yes No Yes No Chen et al. (1987)
6 (Okinawa and Kyushu, Japan) 3,222 1983 0–60 Yes Yes Yes No Kashiwagi et al. (1983)
7 (Israel) 1,411 1982 0–70 Yes Yes Yes No Yodfat et al. (1982)
* The first two studies were also used in the five-state model
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In the light of Fig. 1 which is an extension of the Anderson
and May model (1991), let X(t) represent a stochastic process
defined by a state space, X = {S, L, T, C, R}, where S, L, T,
C, R stand for susceptible, latent period, active viral repli-
cation, the carrier state, and recovery, respectively. For ease
of presentation, the realization of these five states was
assigned from 1 to 5, corresponding to the order of states
defined in the above-mentioned state space, X. Individuals
started at the susceptible state (S), presenting as negative for
HBsAg, then were infected at a rate of k after birth and
entered the latent period (L), with the presence of anti-HBc.
The proportions of vertical and horizontal transmissions are
denoted as f and 1 - f, respectively. HBV replication after
transmission and active viral replication (T), as evidenced by
HBeAg in the serum, developed at a rate of a. After infection,
if the host cleared the virus and developed immunity with
anti-HBc at a rate of x, they were classified as being in the
recovery (R) state. Those who failed to do the same remained
in the carrier state (C), with the presence of HBsAg in the
serum at a rate of e. Few carriers are considered to recover
and gain immunity at a rate of m. Note that the transmission
rates jumping from one state to another state were constant
with time, i.e., they were homogeneous Markov processes,
though differing from the two-state model such that the
process from susceptible to infection was mixed with mul-
tistates wherein the transition rates varied with time.
2.2.1 Intensity matrix
Following Fig. 1, two intensity matrixes were developed:
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where S–R is defined as above. The notations were defined as
follows, k: infection rate after birth; n: infection rate before
birth; a: rate of transition to transient viremia; x: recovery rate
for transient viremia; e: carrier rate;m: recovery rate for carrier.
It should be noted that the parameter of n (infection rate before
birth) was not directly estimated since the infection time was
not exactly known. Instead of estimating n, we modeled the
proportion of vertical transmission (f) and other parameters
(such as a, x, e, and m) contained in Q1. We assumed there was
no latent state for vertical transmission. The proportion of
horizontal transmission was therefore denoted by 1 - f.
2.2.2 Transition probabilities
In this subsection, we developed a series of transition
probabilities during time t denoted by Pij(t) (where i and
j were equal from 1 to 5) corresponding to the intensity
matrix. If the time at birth was set as 0, the transition time
(t) defined above would then be equal to the age at survey,
denoted by a. Each transition probability from state i to
state j at age a was denoted by Pij(a). It should be noted
that although the transition probabilities could be derived
from the current state (i) to the next state (j) in any state
transition between 1 and 5, the state transition began with
the state greater than two was not directly observable and
there was a lacking of empirical data for estimation. We
therefore only focused on the derivation of transition
probabilities starting from state 1 (S: susceptible) with
available empirical data listed in Table 1. According to the
definition mentioned above, conditional probability equa-
tions were developed and can be seen in the Appendix 1.
For estimation of the above model, we first needed to
specify the likelihood function. The notations ua, va, wa, ya,
and za indicated the number in each state: susceptible,
latent period, acute infection, carrier, and recovery at a




ua  log P11 að Þ þ va  log P12 að Þ½
þwa  log P13 að Þ þ ya  log P14 að Þ
þza  log P15 að Þ
Using Study 2 (Table 1) as an example for illustrating
the likelihood function:




þ 18  log P13 7ð Þ þ 10
 log P14 7ð Þ þ 23  log P11 12ð Þ
þ 92  log P12 12ð Þ þ P15 12ð Þ½ 
þ 19  log P13 12ð Þ þ 16  log P14 12ð Þ
þ    þ 14  log P14 64:5ð Þ
We estimated the six parameters in this model by
maximizing the log likelihood function by using the
Newton–Raphson method.
2.3 R0 estimation
Following the SIR model, R0 was inversely proportional to
the ratio of the susceptible population.














where d(.) represents the hazard function of infection.
To cope with the intractability of integration, we used
the intensity matrix (Q) mentioned above to simulate the
proportion of the susceptible population. Let the proba-
bility of being in each state at time t, P(t), be a square,
5 9 5 matrix. If age = t, then P can be written as
P = ADA-1, where A is the eigenvector of matrix Q, and
D is the diagonal matrix whose diagonal elements are the
exponential function of the corresponding eigenvalues of
matrix Q (i.e., Dii ¼ eui t, where ui is ith eigenvalue of Q).
For the details on the derivation of eigenvectors and
eigenvalues of Q, refer to Cox and Miller (1965).
A beta distribution was assigned to the proportion of the
susceptible population (x*), with a range between 0 and 1.
With the estimated x* and total population number (n)
provided by the data, we can calculate the standard error of
the proportion of the susceptible population, S, by the
following formula:
S2 ¼ v  ð1  vÞ
n þ 1 ;
which provided the basis for the estimation of 95 % con-
fidence interval (CI) of R0.
2.4 Cost-effectiveness analysis of population-based
preventive strategies
Two intervention strategies were compared, including the
routine vaccination plus HBIG and the lamivudine-treated
group with routine vaccination included for pregnant
women at the last month before delivery. We used a birth
cohort, consisting of approximately 200,000 newborns in
the year 2008 in Taiwan, as our simulated cohort.
To conduct a cost-effectiveness analysis between the
two intervention strategies, we built a Markov cycle deci-
sion tree by conjoining the temporal natural history of
HBV infection (the upper panel of Fig. 1) developed in
Sect. 2.2 with the previously established Markov process
modeling the sequale of HBV infection (the bottom panel
of Fig. 1) from asymptomatic carrier, through intermediate
Table 2 Parameter estimation in the two-state model
Study (location) Exponential distribution Weibull distribution Log-logistic distribution












0.054 (0.041–0.066) 51.85 (\0.001) 0.080 (0.059 to
0.101)/0.543
(0.424 to 0.663)






0.164 (0.075–0.253) 14.08 (0.050) 2.122 (-5.557 to
9.801)/0.170
(0.012 to 0.327)






0.046 (0.037–0.056) 220.02 (\0.001) 0.024 (-0.0013 to
0.050)/0.610
(0.249 to 0.970)






0.117 (0.087–0.147) 0.95 (0.996) 0.158 (0.062 to
0.254)/0.673
(0.342 to 1.004)






0.1047 (0.066–0.143) 180.81 (\0.001) 0.357 (-0.053 to
0.767)/0.311
(0.145 to 0.478)







0.012 (0.0093–0.015) 8.45 (0.207) 0.015 (0.012 to
0.018)/1.556
(0.934 to 2.179)




0.043 (0.028–0.059) 22.15 (0.001) 0.043 (0.025 to
0.060)/0.799
(0.381 to 1.217)




7 (Israel) 0.015 (0.012–0.018) 24.53 (0.001) 0.010 (0.006 to
0.014)/0.660
(0.484 to 0.837)




The first two studies were also used in the five-state model
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states (including chronic active hepatitis, compensated or
decompensated liver cirrhosis, hepatocelluar carcinoma)
and finally to death from HCC. The detailed decision tree
consisting of both processes is given in Appendix 2.
A Markov cycle tree with one cycle in a year was adopted
to simulate such a complex disease process for each new-
born from birth to 80 years of age. In addition to the
estimated parameters on temporal natural history of HBV
infection, which are shown in Sect. 2.2 and also Fig. 1, the
parameters regarding the sequale of HBV infection were
adopted from a previous study (Hung and Chen 2009). A
cost-effectiveness analysis of two preventive strategies
compared with no vaccination was performed by using an
incremental cost-effectiveness ratio (ICER) indicator
(defined as an additional cost per quality-adjusted life years
(QALYs) over a life time) for assessing whether the pre-
ventive strategy was cost-saving (less cost and more ben-
efit) or cost-effective. The detailed procedures of doing
cost-effectiveness analysis with Markov cycle tree and
their relevant assumptions are delineated in Appendix 2.
3 Results
3.1 Two-state model
Table 2 shows the estimated results of the two-state model
(susceptible to infection) after fitting data from available
studies by the three survival distributions of exponential,
Weibull, and log-logistics functions. It was found from the
comparison between the observed and fitted values that the
exponential distribution had a larger discrepancy than the
two other distributions. The shape parameters obtained
from the Weibull and log-logistic distributions suggest that
the force of infection was not constant, but increased with
time at a decreasing rate (Fig. 2). Compared with the
results using data from the northern areas of Taiwan
(Studies 1 and 3 in Table 1), the scale parameter estimated
from southern area (Study 2) was larger. The cumulative
risk of infection using the above equation showed a sharp
increase in infection starting at birth. This suggests that a
higher infection rate at birth (i.e., vertical transmission)
among subjects in southern areas.
3.2 Five-state stochastic model
Table 3 shows the proportion of vertical transmission was
two times higher in the southern area (Study 2) (80.2 %)
than the northern area (Study 1) (41.4 %). The estimated
transition parameters for the five-state model are also listed
in Table 3. All these transition rates were expressed in the
unit of person-years. After making allowance for the
parameters of transmission mode, the annual infection rate
for susceptible subjects was three times higher in Study 1
(northern area) (0.035) than in Study 2 (southern area)
(0.011). The transition rate (in person-years) from the
latent period to transient viremia was slightly higher in
Study 1 (northern area) (1.112) compared with Study 2
(southern area) (0.072). On the other hand, the annual
transition rate from active viral replication to carrier was
higher in Study 2 (southern area) (0.088) than in Study 1
(northern area) (0.048). Similar findings were observed for
the higher transition rates from active viral replication to
recovery and from carrier to recovery in Study 2 (southern
area) compared with those in Study 1 (northern area).
3.3 Model fitting
The cumulative risks by state are shown in Fig. 3, which
shows there was a lacking of discrepancy between the
expected and observed numbers for southern areas
(v2[25] = 23.875, p = 0.53). In northern areas, the pro-
portion of vertical transmission decreased to 40 %, with
relatively high infection rates after birth (0.035 persons/
year). However, the results of model fitting were not sat-
isfactory (v2[31] = 75.44, p \ 0.001) because of the
sparse data on children aged less than 3 years, which
accounted for the discrepancy between the observed and
expected values, particularly in the states of latency and
recovery in early childhood in northern areas (Fig. 3B-d).
3.4 R0 estimation
The application of annual infection rates derived from the
two-state model using a Weibull distribution yielded the
estimated results of R0, as shown in Table 4. By integrating
the age-dependent infection rates in Table 4, R0 was esti-
mated as 1.24–17.11 by the age of 30. This suggests that
one HBV-infected carrier will spawn 1–17 offspring of
infectious subjects. The estimated R0 was higher in Taiwan
Fig. 2 Comparison of the cumulative risk of infection for the two-
state models with exponential and Weibull distributions
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compared to other countries, with the highest estimation of
11.02 in Kaohsiung, a southern city in Taiwan, compared
to the lowest value of 1.24 in Japan for the age of 30. The
R0 and the 95 % confidence interval (CI) estimated from
the five-state model are also illustrated in Table 5. By
using the five-state model, the R0 at age 30 was estimated
as 4.88 and 7.03 in northern and southern areas, respec-
tively. The discrepancy in the two estimations of R0 by the
two- and five-state models was larger in Study 2 (southern
area of Taiwan). In Taiwan, the R0 was higher in southern
areas compared to the northern areas in both the two- and
five-state models.
3.5 Results of economic appraisal on preventive
strategies
By using the estimated results of the five-state model for
the Studies 1 and 2 together with other parameters and cost
from a previous study (Hung and Chen 2011) as detailed in
Appendix 2, Table 6 shows the results of cost, QALYs and
the incremental cost-effectiveness ratio. As far as the ICER
indicators are concerned, two preventive strategies domi-
nated over no intervention group regardless of study
selected because the ICER values were negative, indicating
more gain in QALY but less cost (cost-saving) for the two
intervention groups as compared with no intervention.
Furthermore, the supplemental lamivudine to routine vac-
cination was also superior to then routine vaccination only
strategy. It is also noted in Table 6 that the preventive
strategies in the southern area were more cost-saving than
those in the northern area as the values of the ICERs were
smaller in the southern area than the northern area.
4 Discussion
Three major findings were demonstrated by consolidating
three related parts from dynamic infection process to eco-
nomic appraisal of intervention strategies with the appli-
cation. The first part is to build a five-state stochastic
process for modeling the temporal natural history of HBV
infection characterized by the unobserved infectious pro-
cess between intermediate state transitions and long-term
disease progression of the sequale of HBV infection taking
both vertical and horizontal transmission into account in
the two areas in Taiwan. Fitting empirical data with the
proposed five state model, we found vertical transmission
and other transmission parameters were different between
the two areas. The chance of vertical transmission was
higher in the south (Study 2, a high endemic area of HBV
infection) than the north (Study 1, a low endemic area of
HBV infection). The second part is the application of
parameters obtained from the five-state model to give area-
dependent estimates of R0, supporting a higher R0 in the
high endemic area compared to the low endemic area.
Finally, conducting an economic appraisal with the
development of a Markov decision tree with the incorpo-
ration of the parameters relating to the five-state stochastic
process and also those pertaining to the Markov process of
the sequale of HBV infection together with the corre-
sponding costs demonstrated the two population-based
preventive strategies (the routine vaccination plus HBIG
and the lamivudine-treated group with routine vaccination)
were more cost-effective or cost-saving (more gain of
QALY and less cost) compared with no intervention. Both
preventive strategies dominated over no intervention (cost-
saving) and even more so in the high endemic area.
There were several novel ideas in methodological
development as well as applications to quantify the tem-
poral natural history of HBV infection and the process of
its sequale. We started from a simple two-state process to
model the transition between susceptible and infection by
using Weibull, log-logistic, and exponential distribution
models. The Weibull and log-logistic distribution can be
adapted to data with non-constant infection rates. The two-
state model was used to quantify the instantaneous rate of
infection with HBV when other information other than
anti-HBc was incomplete from the empirical data, such as
the five other types of data listed in Table 1. In our two-
state model, the Weibull distribution accurately described
Table 3 Parameter estimation in the five-state stochastic model
Transition parameters Study 1-northern area
(Taipei, Taiwan) (95 % CI)
Study 2-southern area
(Pingtung, Taiwan) (95 % CI)
Susceptible (S) ? Latent period (L) (k) 0.035 (0.02897–0.04099) 0.011 (0.00355–0.01845)
Latent period (L) ? Active viral replication (T) (a) 1.112 (0.16735–2.05597) 0.072 (0.04559–0.09919)
Active viral replication (T) ? Carrier (C) (e) 0.048 (0.03079–0.06445) 0.088 (0.04970–0.12538)
Active viral replication (T) ? Recovery (R) (x) 0.119 (0.09293–0.14596) 0.184 (0.12768–0.24015)
Carrier (C) ? Recovery (R) (m) 0.014 (0.00383–0.02387) 0.024 (0.00734–0.04052)
Vertical transmission (f) 0.414 (0.31026–0.51828) 0.802 (0.75325–0.85129)
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Fig. 3 Cumulative risk by state in five-state model
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the process from susceptible to infection states, except in
infants and elderly individuals. The discrepancy for those
of a young age may be due to immature immunity and the
appearance of serum biomarkers. The incident age of
chronic outcomes for HBV infection was within five dec-
ades, and competitive death causes may account for the
discrepancy in the elderly population. Such discrepancy
may also suggest that the HBV infectious process was
heterogeneous with age. This prompted us to consider the
application of stochastic processes to model the temporal
nature of HBV infection as multistate outcomes.
From a methodological viewpoint, in spite of several
previous attempts by using stochastic processes to model
the dynamics of infectious diseases (Mikler et al. 2007;
Reiczigel et al. 2010), this is the first study, to the best of
our knowledge, to develop a five-state stochastic model to
estimate the parameters governing the temporal natural
history of HBV by taking both vertical and horizontal
transmissions based on the two different areas of empirical
data prior to the introduction of HBV vaccine in Taiwan.
Compared with the two-state survival model, the advan-
tages of using the five-state stochastic model are that it
appears to be more flexible to deal with the heterogeneity
of HBV infection as it not only elucidated the instanta-
neous rate of each transition from susceptible through
latent period, active viremia, and until the carrier state or
the recovery state but also estimated the proportion of
vertical and horizontal transmission. In addition, the use of
five-state stochastic process can deal with the censored
problems, that is, when the time to each outcome may not
be exactly known.
The application of stochastic processes also led to a
more precise estimation of R0, particularly in a high
endemic area, as the two-state model did not consider a
mixture of horizontal and vertical transmissions, resulting
in the underestimation of the R0 values for those of young
age and overestimation of the R0 values for adults in areas
where HBV transmission occurred mainly via vertical
routes. The estimated results on R0 from the five-state
model would be more valid than those from the two-state
model.
Translating the temporal natural history of HBV infec-
tion into an R0 gave an indication of the spread of HBV
infection with different transmission routes in different
areas. The reproductive number for HBV infection was
estimated at 0.69–1.11 in the low endemic areas of the
Netherlands and UK (Kretzschmar et al. 2002). In these
areas, the HBV transmission route was environmental with
horizontal transmission, and the spread of HBV infection
was therefore lower in their countries than our study
because vertical transmission was rampant in Taiwan,
particularly in southern area. This was also supported by
the finding that R0 was higher in the south than in the north
because most susceptible individuals became infected via
vertical transmission in southern areas. Mother-to-infant
transmission was usually the major route in high endemic
areas. In Taiwan, at least 40 % of carriers were infected by
their mothers (Beasley et al. 1983b). Furthermore, the
carrier rate rose to 74–90 % if their mothers were HBsAg-
and HBeAg-positive (Beasley et al. 1983a, b). The most
important evidence for the proportion of vertical trans-
mission came from a serological study that took place
within 6 months after birth, which was compatible with the
timing of perinatal infection. Several studies conducted in
Far East Asia before universal vaccination (between 1975
and 1985) showed a 30–70 % transmission rate from an
Table 4 The age of a case and
its corresponding reproductive




























5 1.45 3.59 1.17 1.59 2.46 1.00 1.15 1.08
10 1.95 5.95 1.37 2.36 3.89 1.02 1.37 1.17
15 2.61 8.65 1.63 3.35 5.59 1.05 1.67 1.29
20 3.36 11.47 1.95 4.43 7.39 1.09 2.05 1.43
25 4.16 14.30 2.31 5.53 9.21 1.16 2.49 1.60
30 4.97 17.11 2.71 6.62 11.02 1.24 2.95 1.80
Table 5 The age of a case and its corresponding reproductive
number estimation in the five-state model
Age (years) Study
Study 1-northern area




5 2.03 (1.42–3.59) 5.34 (3.81–7.40)
10 2.42 (2.04–2.97) 5.64 (4.20–8.59)
15 2.88 (2.15–4.34) 5.96 (4.40–9.24)
20 3.43 (2.63–4.93) 6.29 (4.60–9.93)
25 4.09 (3.05–6.22) 6.65 (4.82–10.71)
30 4.88 (3.78–6.88) 7.03 (5.03–11.49)
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asymptomatic carrier mother to her infant (Stevens et al.
1975; Xu et al. 1985). These reported proportions of ver-
tical transmission were similar to that in our study.
It would be of great interest to throw light on the tem-
poral natural history of HBV infection and elucidate the
transmission route and the estimation of not only the
instantaneous rates of virus replication but also the chance
of becoming a carrier or recovery after acute infection.
Such modeling also forms an essential underlying frame-
work for conducting a cost-effectiveness analysis that
compares different population-based preventive strategies
by unifying the temporal natural history of HBV infection
with the Markov process on the progression of its sequale
to form a Markov decision tree given the assignment of
relevant costs corresponding to each health state during the
evolution of the disease process. This would provide the
foundation for the economic appraisal of population-based
preventive strategies like universal vaccination and HBV
immunoglobulin. The universal vaccination of infants was
feasible and effective for reducing the number of HBV
carriers by preventing vertical transmission after birth and
horizontal transmission by long-term immunity. Treatment
with HBV immunoglobulin was effective for reducing
vertical transmission when combined with vaccination. As
the effectiveness of both intervention strategies in reducing
vertical transmission or horizontal transmission was highly
dependent on the transmission route and also the rate of
being carrier or the recovery that may differ according to
location, it is of paramount importance to elucidate the
temporal natural history of HBV infection before assessing
the effectiveness of these strategies in reducing the sequale
of chronic liver diseases and death from HCC. On the cost
side, as these population-based intervention strategies often
require enormous costs the balance between cost and
effectiveness in terms of incremental cost-effectiveness
ratio (ICER), a useful indicator used in cost-effectiveness
analyses, would be of great value to health-policy makers
because the results of ICERs may vary from area to area
depending on the underlying transmission routes and the
rate of being a carrier or recovering.
Based on the parameters estimated from the high-
endemic area of Taiwan, relative to other Western coun-
tries, the implementation of preventive strategies such as
universal vaccination in infants and maternal lamivudine
use was cost-saving compared with no intervention.
Although the results were consistent regardless of northern
or southern areas, it can be seen that costs were saved even
more in the south than in the north. However, it should be
noted that for areas with low endemic HBV infection and a
low proportion of vertical transmission such as in Western
countries, such preventive strategies may neither be cost-
saving nor even cost-effective. It is hoped that our pro-
posed five-state stochastic model can be extended to shed
light on how vaccination and anti-virus treatment can stop
the spread of HBV as they did in two prior studies
(O’Leary et al. 2010; Pang et al. 2010) and can also assess
how different transmission resources can lead to HBV
infection or other cross-infection as seen in another pre-
vious study (Aylward et al. 1995).
The limitations of this study were three-fold. Firstly, our
five-state stochastic model, based on the estimated
parameters from Table 3, fitted well in the southern area (a
high endemic area), but there was inconsistency in the
northern area (a low endemic area), particularly in the
category of children aged under 6 years. As the number of
latent state and recovery within this age range was sparse,
it was difficult to assess whether random fluctuation or
inadequacy of the model led to a poor fit. Another reason
for the inconsistency may stem from the underestimation of
the transmission rate from the susceptible to latent period
Table 6 Results of cost-effectiveness analysis in northern and southern areas in Taiwan
Study Strategy Cost (US $) Effectiveness
(QALY)
ICER
Study 1-northern area (Taipei, Taiwan) Universal vaccination ? HBIG ? LAM 6,904 70.1363 -13,239 (dominant)
Universal vaccination ? HBIG 8,255 70.0416 -13,218 (dominant)
No vaccination 69,248 65.4272
Study 2-southern area (Pingtung, Taiwan) Universal vaccination ? HBIG ? LAM 4,647 70.3021 -13,416 (dominant)
Universal vaccination ? HBIG 7,635 70.0899 -13,383 (dominant)
No vaccination 64,153 65.8668
QALY quality-adjusted life-year
ICER ratio of incremental cost (the difference of cost between a specific strategy and no vaccination) to incremental effectiveness (the difference
of effectiveness between a specific strategy and no vaccination)
HBIG hepatitis B immunoglobulin given within 24 h after birth
LAM lamivudine-treated pregnant women at the last month before delivery. The estimation is based on simulating a disease process for each
newborn from birth to 80 years of age. Cost and effectiveness were presented on the basis of life-time per person
Stoch Environ Res Risk Assess (2014) 28:611–625 621
123
states. We compared the observed data from Study 4 with
the estimated values using the parameters of Study 1 (the
data from Studies 1 and 4 were from Taipei), and the
estimated number of HBsAg-positive subjects fitted well,
but the number of susceptible subjects was underestimated.
Due to the discrepancy between the expected number and
the observed one, the temporal natural history for the
children below 6 years of age in low endemic areas should
be validated and the interpretation should be made with
caution.
A second limitation could be that the virus was divided
into four major serotypes (adr, adw, ayr, ayw) based on
antigenic epitopes present on its envelope proteins. The
genotypes had a distinct geographical distribution and
played an important role in the progression of HBV
infection. However, there was no population study of viral
subtype available before universal vaccination.
In addition, the clinical outcome of HBV infection was
determined by the virological factors and host factors.
There were several host genetic factors that modulated the
immune response to HBV infection and the process of viral
clearance. Different HLA phenotypes and tumor necrosis
factor-a (TNF-a) gene polymorphisms associated with
recovery from HBV infection in different areas have been
observed in Taiwan.(Wu et al. 2004; Kao et al. 2010) The
different HLA phenotypes in different areas may be the
reason for the higher rate of transition from viremia to
recovery and carrier to recovery for the southern versus
northern populations. Further incorporation of information
on viral subtypes or HLA phenotypes and TNF-a gene
polymorphisms into our formula of hazard function as a
covariate may be a possible solution.
Thirdly, the difference between southern and northern
areas may be one of the reasons for the distinct pattern of
HBV infection process in Taiwan. As the dynamics of an
infectious disease must be dependent on the host as well as
the infectious agent, the environment socioeconomic status
may be an important determinant in the process of infec-
tion. Unfortunately, most studies conducted in Asia suffer
from a lack of description about socioeconomic status. The
comparison between the two areas in Taiwan provides
some indications of this aspect insofar as Study 2 was
situated in a southern area classified as a rural city whereas
Study 1 was located in a northern urban city. The disparity
between the two areas in Taiwan might be due to the level
of urbanization. However, as we only studied two areas
with the five-state stochastic model and the fact that the
number of children included in Study 1 (urban) was small,
we are simply unable to generalize our results based on two
studies. The generalizability of our five-state model should
be verified in future study.
In conclusion, we developed a five-state stochastic
model to quantify the proportion of maternal (vertical) and
environmental (horizontal) transmission and also the sub-
sequent transition to active viremia, carrier, and resolution
of HBV in the two areas with high and low prevalence of
HBV infection. These parameters were further converted to
estimate the basic reproductive number to reflect the spread
of HBV infection. Economical evaluation was also con-
ducted by using a Markov cycle tree unifying the temporal
natural history of HBV infection with the process of the
sequale of HBV infection to demonstrate cost-saving
results of various population-based preventive strategies.
All these findings seem area-dependent. Consolidating all
information on the temporal natural history of HBV
infection, the estimation of basic reproductive number, and
economic appraisal of population-based preventive strategy
can serve as valuable aids for health policy-makers in
designing effective preventive strategies in other countries
worldwide where HBV are still prevalent. However, the
empirical findings on transmission routes and the temporal
evolution of HBV infection varying with areas should be
considered with caution as only two studies were modeled.
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Appendix 1
1. Transition probability from susceptible to carrier,
P14 að Þ ¼ P susceptible ! carrier at age að Þ
¼ P carrier through vertical transmission
Q1½  at age a

þ P carrier through horizontal transmission
























Recall that those who were vertical transmission would
pass through active viral replication assuming no latent
state.
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2. Transition probability from susceptible to recovery,
P15 að Þ ¼ P susceptible ! recovery at age að Þ
¼ P recovery through vertical transmissionð
Q1½  at age aÞ
þ P recovery through horizontal transmissionð
Q2½  at age aÞ
¼ P susceptible ! transient viremia ! recoveryð
through vertical transmission Q1½  at age aÞ
þ P susceptible ! transient viremia ! recoveryð
through horizontal transmission Q2½  at age aÞ
þ P susceptible ! carrier ! recovery throughð
vertical transmission Q1½  at age aÞ
þ P susceptible ! carrier ! recovery throughð
horizontal transmission Q2½  at age aÞ




















































3. Transition probability from susceptible to transient
viremia,
P13 að Þ¼ P susceptible ! transient viremia at age að Þ
¼ P transient viremia throughð
transmission Q1½  at age aÞ



















4. Transition probability from susceptible to latent
period,







5þ f  eka
5. Transition probability staying in susceptible,
P11 að Þ ¼ 1  fð Þ  eka
Appendix 2
Two intervention strategies
The two intervention strategies, as opposed to no inter-
vention, that were compared in a cost-effectiveness anal-
ysis were routine vaccination and hepatitis B
immunoglobulin (HBIG) injection (present strategy for
nationwide immunization program) and the lamivudine-
treated group with routine vaccination. Note that lamivu-
dine was prescribed in addition to routine vaccination for
pregnant women at the last month before delivery (Sup-
plementary Fig. 1).
Markov decision tree and assignment of parameters
As mentioned in the text, we built up a Markov cycle tree
by conjoining the five-state stochastic process pertaining to
the temporal natural history of HBV infection (the upper
panel of Fig. 1 and the upper panel of Supplementary
Fig. 1b) with a previously-designed Markov process for the
sequale of HBV infection (the lower panel of Fig. 1 and
Supplementary Fig. 1b). The decision tree starts from the
three decision nodes of no intervention, routine vaccination
and hepatitis B immunoglobulin (HBIG) injection, and the
lamivudine-treated group with routine vaccination. The
basic idea for constructing the Markov decision tree is to
construct the tree structure for the baseline group (no
intervention) as it represents the subjects following the
temporal natural history of HBV infection and also the
Markov process for the sequale of HBV infection. As
depicted in Supplementary Fig. 1, the detailed tree struc-
ture for the temporal natural history of HBV takes other
causes of death into account. Each node represents the
chance of moving from the current state to the possible
outcomes in the next cycle following the Markov
assumption. For example, the susceptible state at the cur-
rent time may be in latent state or still in the susceptible
state in the next cycle if the patient did not die from other
causes of death. Based on the Markov assumption, annual
transition probabilities for each chance node were com-
puted by the application of instantaneous rates listed in
Table 3. For example, the annual transition probability
from susceptible to latent state (h1) was estimated by the
transition parameter k in Table 3.
h1 ¼ 1  expðkÞ
The estimations of h2–h5 were also derived from a, e, x, m
in Table 3 in a similar manner. The annual transition
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probabilities for each transition are listed in Supplementary
Table 1.
The lower panel of Supplementary Fig. 1b gives a
delineation of the Markov cycle tree for the evolution of
the sequale of HBV infection starting from asymptomatic
carrier until death from HCC. Note that the terminal status
(denoted by the triangle) of each tree represents the state at
the end of each cycle and would return the corresponding
state to the beginning of the Markov node (denoted by the
circle (M)), following the Markov assumption except death
defined as an absorbing state that no longer moves. The
entire cohort was simulated by using the Markov cycle tree
in this way to give a series of outcomes during HBV
infection and also various sequale after asymptomatic
carrier state for the baseline group (no intervention). The
parameters related to the Markov cycle tree on the pro-
gression to the sequale of HBV infection and also the
utility for each state (for more detail, see the previous study
(Hung and Chen 2009)) are shown in the decision tree.
The tree structures for the two intervention groups were
similar to the baseline group. The only difference between
the intervention group and the baseline group was the
assignment of the parameters by changing the transmission
parameters governing the temporal natural history of HBV
infection according to the efficacy of intervention. For
example, the efficacy of vaccine plus HBIG and lamivu-
dine in reducing vertical transmission vertical transmission
through the efficacy of both interventions were adjusted
between the susceptible, the latent state, and immunity in
the tree structure. Listed in Supplementary Table 1, these
base-case estimates were assigned to the decision tree
structure. For the parameters relating to the temporal nat-
ural history of HBV infection, we did not specify their
distribution because they were estimated from the empiri-
cal data. The parameters related to the sequale of HBV
infection were assigned with gamma or beta distribution by
using Bayesian conjugated method to update the parame-
ters from different studies.
Assignment of cost parameters
In addition to the cost involved in each specific test, since
the Markov cycle tree can keep track of each disease state
in each cycle, it is very straightforward to assign the cor-
responding cost parameter to each disease. Detailed in
Supplementary Table 2 are the base-case estimates of cost,
which were further converted to $US with year 2008 val-
ues. The indirect costs were approximated by production
loss due to early death, which was estimated by using
Taiwan’s per capita income multiplied by the offset
between the age of death and age of retirement based on
the capital approach (Supplementary Table 2). All analyses
were carried out from a societal perspective. All costs were
discounted at 3 % annually.
Outcome measures
The outcome related to effectiveness is quality-adjusted-
life-year (QALY) gained in each preventive strategy. Note
that the utility values are those quoted from a previous
cost-effectiveness study on the prevention of hepatitis B in
Asian and Pacific Islander adults, as described in Supple-
mentary Table 1.
Probability analyses
A series of incremental cost-effectiveness ratios (ICERs)
were simulated with probabilistic sensitivity analysis,
employing Monte Carlo simulation based on the specific
assigned distributions of parameters mentioned above.
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